glp 1 stop taking New research is a closer look at what can happen a year or more after people taking GLP-1 medications GLP-1 weight-loss medications: 60% of

Metabolic and hormonal changes after laparoscopic roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial

The FDA announced the action on April 15, 2026 (Federal Register notice April 16), and the peptides come off the Category 2 list effective April 23, 2026

The Market Size is Growing at a CAGR of 2.37% from 2023 to 2033 The South Africa Diabetes Drugs Market Size is Expected to Reach USD 420.72 Million by 2033 Get more details on this report - Request Free Sample PDF The South Africa Diabetes Drugs Market Size is Anticipated to Reach USD 420.72 Million by 2033, Growing at a CAGR of 2.37% from 2023 to 2033

To compensate, the pancreas secretes more insulin in an effort to move sugar into the cells and maintain normal blood glucose levels

In a recent clinical trial, over 2,500 individuals classified as obese or overweight experienced significant weight loss in the first of Tirzepatide's weight loss studies

Machine learning and deep learning for the pharmacogenomics of antidepressant treatments